• Login
• Home
• About
• Current
• Archives
• Search
• Submissions
• Board
• SEEd

Home > Archives > Vol 5, No 4S (2011)

Table of Contents

Case report

Imatinib dose optimisation following the disease progression in a patient with metastatic GIST Mariangela Parodi, Monica Boitano, Luciano Canobbio

PDF 3-6

Imatinib as adjuvant therapy for high risk GIST: a case report Patrizia Lista, Agostino Ponzetti

PDF 7-12

Appropriate durations of adjuvant imatinib in patients with high-risk gastrointestinal stromal tumor (GIST) the better choice, for the year 2010 Lucia Tozzi

PDF 13-16